ACZONE (Allergan, Inc.)
Welcome to the PulseAid listing for the ACZONE drug offered from Allergan, Inc.. This Sulfone [EPC],Sulfones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | dapsone |
| SUBSTANCE NAME: | DAPSONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Sulfone [EPC],Sulfones [Chemical/Ingredient] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | GEL |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-06-24 |
| END MARKETING DATE: | 0000-00-00 |
ACZONE HUMAN PRESCRIPTION DRUG Details:
| Item Description | ACZONE from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/g) |
| START MARKETING DATE: | 2009-06-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0023-3670_959d3017-c7b5-434e-bc00-370c3f27bb21 |
| PRODUCT NDC: | 0023-3670 |
| APPLICATION NUMBER: | NDA021794 |
Other DAPSONE Pharmaceutical Manufacturers / Labelers:
